Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISCAN: Gefitinib vs Chemotherapy in Advanced NSCLC
NCT01404260Phase 3Completed
- Sponsor
- Guangdong Association of Clinical Trials
- Start
- Jun 2011
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gefitinib in lung adenocarcinoma (LUAD), sponsored by Guangdong Association of Clinical Trials. Started Jun 2011; status: completed.
02
Drugs
03
Conditions
lung adenocarcinoma (LUAD)
Beyond the preview
Go deeper on NCT01404260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404260.